Disease caused by decreased platelet production can be augmented by platelet-stimulating agents that interact with the transmembrane domains of the thrombopoietin receptors, thereby complementing native thrombopoietin that binds with the extracellular domains.
Keywords: Airbrush, Color, 3D, Advertising / Marketing, Biotechnology, Cell biology / Histology, Disease Management, Pharmacology, Mechanism of Action (MOA)
© Cynthia Turner